Bianling Feng

Xi'an Jiaotong University — China

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

10h-index266citations37works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacovigilance and Adverse Drug Reactions(11), Diabetes Management and Education(5), Chronic Disease Management Strategies(5), Pharmaceutical studies and practices(5), Pharmaceutical Practices and Patient Outcomes(4)

Publications37 total

Correction: Effects of a family-doctor-led community intervention model on self-management and medication taking in patients with type 2 diabetes mellitus: a randomized controlled trial
BMC Public Health·2025Open Access
Constructing an evaluation framework for primary pharmacovigilance systems in developing countries: a case study from China
Frontiers in Pharmacology·2025Open Access
Global, regional, and national trends and inequality analysis of the total cancers and 29 cancer types from 1990 to 2021
BMC Public Health·2025Open Access
Effects of a family-doctor-led community intervention model on self-management and medication taking in patients with type 2 diabetes mellitus: a randomized controlled trial
BMC Public Health·2025· 2 citedOpen Access
Identification and trajectory of multimorbidity patterns among older people in China: a longitudinal study based on the China health and retirement longitudinal study 2011–2020 data
Frontiers in Public Health·2025· 3 citedOpen Access
Pharmacovigilance-related events, disease burden and overall efficiency of care in european countries, 1990-2021
Frontiers in Pharmacology·2025· 1 citedOpen Access
Self-management knowledge, attitudes, and behaviors among patients with type 2 diabetes mellitus in a community of western China: A cross-sectional study
Geriatric Nursing·2024· 2 cited
Safety assessment of anti-B cell maturation antigen chimeric antigen receptor T cell therapy: a real-world study based on the FDA adverse event reporting system database
Frontiers in Immunology·2024· 7 citedOpen Access
Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study
International Journal of Clinical Pharmacy·2024· 6 cited
The short- and long-term effects of community-family-doctor-based type 2 diabetes self-management interventions
Public Health·2024· 2 cited
Safety analysis of therapeutic drugs for breast cancer patients and construction of a predictive model for serious adverse drug reactions
European Journal of Clinical Pharmacology·2023· 3 cited
Safety analysis of antineoplastic drugs for lung cancer: a retrospective analysis based on Shaanxi Province in Western China
Expert Opinion on Drug Safety·2023· 3 cited
Use of Failure Mode and Effects Analysis (FMEA) for Risk Analysis of Drug Use in Patients with Lung Cancer
International Journal of Environmental Research and Public Health·2022· 8 citedOpen Access
Effects of community family doctors-led intervention for self-management and medication adherence in type 2 diabetes mellitus patients: study protocol of a cluster randomised controlled trial
BMJ Open·2022· 8 citedOpen Access
A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China
BMC Health Services Research·2022· 18 citedOpen Access
Assessment of medication adherence, medication safety awareness and medication practice among patients with lung cancer: A multicentre cross‐sectional study
Health Expectations·2022· 10 citedOpen Access
Predictors of Glycemic Control among Patients with Type 2 Diabetes in Western China: A Multi-center Cross Sectional Study
Biological and Pharmaceutical Bulletin·2021· 11 citedOpen Access
2013－2018年西安市各级医院第一批国家重点监控药品不良反应/不良事件分析
现代药物与临床·2021
Knowledge, attitude, and practice regarding pharmacovigilance among the general public in Western China: a cross-sectional study
Current Medical Research and Opinion·2020· 21 cited
Comparison of Three Different Data Sources of Adverse Drug Reactions Using Adverse Drug Reaction Data of Fluorouracil for Gastric Cancer as an Example
Biological and Pharmaceutical Bulletin·2020· 2 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Shuzhi Lin(14), Biqi Ren(11), Shuang Lei(11), Wang Ning-sheng(8), Yufang Xiang(7), Xiaoying Zhu(7), Lin Yin(6), Rui Niu(5), Wei Liu(4), Qian Liu(4), Yue Chen(3), Xiaoying Zhu(3), Shimin Yang(2), Yue Chen(2), Yue Chen(2), Qian Liu(2), Jiadong Guo(2), Yifang Shen(2), Wei Liu(2), Jun Li(2)